Sequencing and cardiac expression of natriuretic peptide receptor 2 (NPR-B) in Sus Scrofa

被引:18
作者
Del Ry, Silvia
Cabiati, Manuela
Lionetti, Vincenzo
Colotti, Chiara
Maltinti, Maristella
Emdin, Michele
Recchia, Fabio A.
Giannessi, Daniela
机构
[1] CNR, Inst Clin Physiol, Lab Cardiovasc Biochem, I-56124 Pisa, Italy
[2] Scuola Super Sant Anna, Med Sect, Pisa, Italy
[3] New York Med Coll, Dept Physiol, Valhalla, NY USA
关键词
natriuretic peptide receptor-B; Sus Scrofa; mRNA; cardiac tissue;
D O I
10.1016/j.peptides.2007.05.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The cardiovascular actions of the C-type natriuretic peptide (CNP) are mainly mediated by the interaction with natriuretic peptide receptor-B (NPR-B). The aim of this study was to identify the sequence of NPR-B in Sus Scrofa, which is not present in GenBank, to verify the expression of NPR-B in the different cardiac chambers of normal pigs and evaluate its homology with murine and human species. Using the guanidinium thyocyanate-phenol-chloroform method, we extracted total RNA from samples obtained from heart of mouse and from the atrium, ventricle, and septum of normal pigs. Pig NPR-B mRNA was sequenced using polymerase chain reaction primers designed from mouse consensus sequences. Sus Scrofa natriuretic peptide receptor 2 mRNA, 1-396 bp, was submitted to GenBank (accession number DQ487044). The presence of NPR-B at mRNA level was detected in all the cardiac chambers; moreover, the bands obtained from pig cardiac tissue shared a 93% sequence homology with a region of the mouse NPR-B and a 95% sequence homology with Homo sapiens. Therefore, NPR-B sequencing provides a new tool to investigate the role of CNP under physiological and pathological conditions in the experimental and clinical setting. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1390 / 1396
页数:7
相关论文
共 28 条
[1]
Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance [J].
Abassi, Z ;
Karram, T ;
Ellaham, S ;
Winaver, J ;
Hoffman, A .
PHARMACOLOGY & THERAPEUTICS, 2004, 102 (03) :223-241
[2]
Endothelium-derived C-type natriuretic peptide: more than just a hyperpolarizing factor [J].
Ahluwalia, A ;
Hobbs, AJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (03) :162-167
[3]
Induction of myocardial connective tissue growth factor in pacing-induced heart failure in pigs [J].
Ahmed, MS ;
von Lueder, TG ;
Oie, E ;
Kjekshus, H ;
Attramadal, H .
ACTA PHYSIOLOGICA SCANDINAVICA, 2005, 184 (01) :27-36
[4]
C-type natriuretic peptide [J].
Barr, CS ;
Rhodes, P ;
Struthers, AD .
PEPTIDES, 1996, 17 (07) :1243-1251
[5]
Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI [10.1093/nar/gkr1065, 10.1093/nar/gkp985, 10.1093/nar/gkh121]
[6]
Chen HH, 1998, J CARDIOVASC PHARM, V32, pS22
[7]
DEL RS, 2006, J CARDIOVASC MED, V7, P397
[8]
DEL RY, 2007, PEPTIDES, V28, P1068
[9]
C-type natriuretic peptide plasma levels increase in patients with chronic heart failure as a function of clinical severity [J].
Del Ry, S ;
Passino, C ;
Maltinti, M ;
Emdin, M ;
Giannessi, D .
EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (07) :1145-1148
[10]
Fu Xiang-hua, 2006, Zhonghua Yi Xue Za Zhi, V86, P1129